People: NVIDIA Corp (NVDA.OQ)
6 Dec 2013
Mr. Mark L. Perry is Independent Director of NVIDIA Corp. He is an entrepreneur-in-residence at Third Rock Ventures, a venture capital firm. Mr. Perry is also the chairman of Pathway Therapeutics and a member of the board of directors of MyoKardia, Inc., both private biotechnology companies, and has served as an independent board member for several biotechnology and high technology companies. From 2007 to 2011, Mr. Perry served as the president and chief executive officer and member of the board of directors of Aerovance, Inc., a biopharmaceutical company. Prior to joining Aerovance, Mr. Perry served as the senior business advisor for Gilead Sciences, Inc., a biopharmaceutical company. Mr. Perry was an executive officer of Gilead from 1994 to 2004, serving in a variety of capacities, including general counsel, chief financial officer and, most recently, executive vice president of operations. From 1981 to 1994, Mr. Perry was with the law firm of Cooley LLP in San Francisco and Palo Alto, California, serving as a partner of the firm from 1987 until 1994. From 2003 to 2009, Mr. Perry served as a member of the board of directors of Nuvelo, Inc. Mr. Perry holds a B.A. degree in History from the University of California, Berkeley and a J.D. degree from the University of California, Davis.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|